{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:22:33Z","timestamp":1775503353836,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013816","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000}}],"reference-count":92,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013816.pub2","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:47:18Z","timestamp":1738046838000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion"],"prefix":"10.1002","volume":"2025","author":[{"given":"Brett","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine; Montefiore Medical Center\/Albert Einstein College of Medicine; Bronx USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Phan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services; Yale New Haven Hospital CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Pasupuleti","sequence":"additional","affiliation":[{"name":"Scientific Services; Oxford PharmaGenesis, Inc.; Newtown PA 18940 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuani M","family":"Roman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice; University of Connecticut; Storrs CT 06269 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice; University of Connecticut; Storrs CT 06269 USA"},{"name":"Unidad de Revisiones Sistem\u00e1ticas y Meta-an\u00e1lisis (URSIGET), Vicerrectorado de Investigaci\u00f3n; Universidad San Ignacio de Loyola (USIL); Lima Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"10.1002\/14651858.CD013816.pub2-BIB0001|cit1","first-page":"1411","article-title":"Pacemaker and defibrillator surgery without interruption of oral anticoagulation: results of the Bridge or continue Coumadin for device surgery randomized controlled trial (Bruise Control) (LB01-02)","volume":"10","author":"Birnie","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/HCO.0b013e32831bef53","article-title":"Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design","volume":"24","author":"Birnie","year":"2008","journal-title":"Current Opinion in Cardiology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2019.04.066","article-title":"Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: a secondary analysis of the BRUISE CONTROL trial","volume":"288","author":"Essebag","year":"2019","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0005|cit5","first-page":"e007545","article-title":"Effect of direct oral anticoagulants, warfarin, and antiplatelet agents on risk of device pocket hematoma: combined analysis of BRUISE CONTROL 1 and 2","volume":"12","author":"Essebag","year":"2019","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0006|cit6","unstructured":"Ottawa Heart Institute Research Corporation Bridge or continue Coumadin for device surgery randomized controlled trial (BRUISECONTROL) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00800137"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0007|cit7","first-page":"e450","article-title":"A randomized controlled rrial of continued versus Interrupted novel oral anti-coagulant at the time of device surgery (BRUISE CONTROL-2)","volume":"136","author":"Birnie","year":"2017","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ahj.2015.12.007","article-title":"Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery inpatients with moderate to high risk of arterial thromboembolic events: the BRUISECONTROL-2 trial","volume":"173","author":"Essebag","year":"2016","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0010|cit10","first-page":"e007545","article-title":"Effect of direct oral anticoagulants, warfarin, and antiplatelet agents on risk of device pocket hematoma: combined analysis of BRUISE CONTROL 1 and 2","volume":"12","author":"Essebag","year":"2019","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0011|cit11","unstructured":"Strategy of continued versus interrupted novel oral anti-coagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events (BRUISECONTROL2) https:\/\/clinicaltrials.gov\/study\/NCT01675076"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2010.12.016","article-title":"Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial","volume":"8","author":"Cheng","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0013|cit13","unstructured":"Randomized study of the use of warfarin during pacemaker or ICD implantation in patients requiring long term anticoagulation https:\/\/clinicaltrials.gov\/study\/NCT00721136"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013816.pub2-BIB0014|cit14","first-page":"695","article-title":"Safety of anticoagulation with uninterrupted NOAC vs interrupted NOAC in patients requiring an implantable cardiac device","volume":"38","author":"Colaiori","year":"2017","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0015|cit15","first-page":"526","article-title":"Is warfarin pause necessary for pacemaker implantation? The FinPAC Study","volume":"33","author":"Airaksinen","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.ijcard.2013.06.022","article-title":"Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment - the FinPAC study","volume":"168","author":"Airaksinen","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0017|cit17","unstructured":"Anticoagulant therapy during pacemaker implantation (FINPAC) https:\/\/clinicaltrials.gov\/study\/NCT00479362"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0018|cit18","unstructured":"Tapered warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation (PACEBRIDGE) https:\/\/clinicaltrials.gov\/study\/NCT02094157"},{"issue":"4","key":"10.1002\/14651858.CD013816.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.thromres.2014.07.028","article-title":"Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial","volume":"134","author":"Schulman","year":"2014","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/pace.13482","article-title":"Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: a single-center randomized prospective pilot trial","volume":"41","author":"Ricciardi","year":"2018","journal-title":"Pacing and Clinical Electrophysiology: PACE"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013816.pub2-BIB0021|cit21","first-page":"S32","article-title":"Pacemaker and implanted cardioverter defibrillator without reversal of DOAC therapy","volume":"55","author":"Santomauro","year":"2019","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1880\u20134","DOI":"10.1093\/eurheartj\/ehp194","article-title":"Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial","volume":"30","author":"Tolosana","year":"2009","journal-title":"European Heart Journal"},{"issue":"1p2","key":"10.1002\/14651858.CD013816.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"511\u20134","DOI":"10.1046\/j.1460-9592.2003.00084.x","article-title":"Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients","volume":"26","author":"Al-Khadra","year":"2003","journal-title":"Pace - Pacing and Clinical Electrophysiology"},{"issue":"9","key":"10.1002\/14651858.CD013816.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1183\u20137","DOI":"10.1093\/europace\/eup212","article-title":"Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation","volume":"11","author":"Cheng","year":"2009","journal-title":"EP Europace"},{"issue":"4","key":"10.1002\/14651858.CD013816.pub2-BIB0025|cit25","first-page":"JC7","article-title":"Warfarin continuation was better than heparin bridging during pacemaker or ICD surgery","volume":"159","author":"DeLoughery","year":"2013","journal-title":"ACP Journal Club"},{"issue":"10","key":"10.1002\/14651858.CD013816.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1630\u20136","DOI":"10.1093\/europace\/euw409","article-title":"Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial","volume":"19","author":"Essebag","year":"2017","journal-title":"EP Europace"},{"issue":"4","key":"10.1002\/14651858.CD013816.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1540-8159.2010.02703.x","article-title":"Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios","volume":"33","author":"Ghanbari","year":"2010","journal-title":"Pace - Pacing and Clinical Electrophysiology"},{"issue":"3","key":"10.1002\/14651858.CD013816.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1540-8159.2004.00441.x","article-title":"Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy","volume":"27","author":"Giudici","year":"2004","journal-title":"Pacing Clinical Electrophysiology"},{"issue":"9","key":"10.1002\/14651858.CD013816.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1540-8159.1998.tb00271.x","article-title":"Outpatient pacemaker procedures in orally anticoagulated patients","volume":"21","author":"Goldstein","year":"2006","journal-title":"Pace - Pacing and Clinical Electrophysiology"},{"issue":"3","key":"10.1002\/14651858.CD013816.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"333\u201340","DOI":"10.1007\/s00380-016-0879-x","article-title":"Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices","volume":"32","author":"Ishibashi","year":"2017","journal-title":"Heart and Vessels"},{"issue":"6","key":"10.1002\/14651858.CD013816.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.lpm.2008.08.012","article-title":"Early complications after insertion of pacemaker","volume":"38","author":"M\u00e9neret","year":"2009","journal-title":"Presse Medicale"},{"issue":"4","key":"10.1002\/14651858.CD013816.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"441\u20136","DOI":"10.1007\/s00380-017-1064-6","article-title":"Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy","volume":"33","author":"Pecha","year":"2018","journal-title":"Heart and Vessels"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013816.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"ehy563.P4808","DOI":"10.1093\/eurheartj\/ehy563.P4808","article-title":"Edoxaban and implantable cardiac device interventions - insights from the ENGAGE AF-TIMI 48 trial","volume":"39","author":"Steffel","year":"2018","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD013816.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.4022\/jafib.1467","article-title":"Pacemaker implantation in elderly patients: safety of various regimens of anticoagulant therapy","volume":"9","author":"Terekhov","year":"2017","journal-title":"Journal of Atrial Fibrillation"},{"issue":"2","key":"10.1002\/14651858.CD013816.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ahj.2009.06.005","article-title":"Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin","volume":"158","author":"Tischenko","year":"2009","journal-title":"American Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD013816.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/pace.12935","article-title":"Analysis of complications in outpatient ICD surgery on or off warfarin anticoagulation","volume":"39","author":"Tolat","year":"2016","journal-title":"Pace - Pacing and Clinical Electrolyphysiology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0037|cit37","unstructured":"Anticoagulant therapy with warfarin during pacemaker installation - pacemaker-warfarin https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2005-000390-22\/FI"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.joa.2015.12.003","article-title":"Management of antithrombotic therapy during cardiac implantable device surgery","volume":"32","author":"AlTurki","year":"2016","journal-title":"Journal of Arrhythmia"},{"issue":"22","key":"10.1002\/14651858.CD013816.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"44","key":"10.1002\/14651858.CD013816.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD013816.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2010.12.016","article-title":"Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial","volume":"8","author":"Cheng","year":"2011","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1002\/14651858.CD013816.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","article-title":"Extended thromboprophylaxis with betrixaban in acutely ill medical patients","volume":"375","author":"Cohen","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2020.02.007","article-title":"Non-vitamin K oral anticoagulants at the time of cardiac rhythm devicesurgery: a systematic review and meta-analysis","volume":"188","author":"Creta","year":"2020","journal-title":"Thrombosis Research"},{"issue":"43","key":"10.1002\/14651858.CD013816.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/pace.12665","article-title":"Pocket hematoma: a call for definition","volume":"38","author":"De Sensi","year":"2015","journal-title":"Pace"},{"issue":"3","key":"10.1002\/14651858.CD013816.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clinical Trials"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nec.2018.06.003","article-title":"Anticoagulants: pharmacokinetics, mechanisms of action, and indications","volume":"29","author":"DeWald","year":"2018","journal-title":"Neurosurgery Clinics of North America"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1182\/blood-2011-02-329979","article-title":"Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach","volume":"117","author":"Douketis","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD013816.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013816.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Internal Medicine"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/pace.12517","article-title":"Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis","volume":"37","author":"Du","year":"2014","journal-title":"Pace"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-017-0137-1","article-title":"Perioperative management of patients on direct oral anticoagulants","volume":"15","author":"Dubois","year":"2017","journal-title":"Thrombosis Journal"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0055|cit55","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2016.01.009","article-title":"Clinical significant pocket hematoma increases long-term risk of device infection","volume":"67","author":"Essebag","year":"2016","journal-title":"Journal of the American College Of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD013816.pub2-BIB0057|cit57","first-page":"700","article-title":"Interpreting estimates of treatment effects: implications for managed care","volume":"33","author":"Faraone","year":"2008","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1160\/TH12-07-0498","article-title":"Oral anticoagulation continuation compared with heparin bridgingtherapy among high risk patients undergoing implantation of cardiac rhythm devices","volume":"108","author":"Feng","year":"2012","journal-title":"Thrombosis and Haemostosis"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0059|cit59","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"6","key":"10.1002\/14651858.CD013816.pub2-BIB0060|cit60","first-page":"442","article-title":"Diagnosis and treatment of atrial fibrillation","volume":"94","author":"Gutierrez","year":"2016","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0061|cit61","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0062|cit62","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpson M, Li T, Page MJ, et al, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0063|cit63","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0064|cit64","unstructured":"Higgins JP Eldrige S Tianjing L Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpson M, Li T, Page MJ, et al, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0065|cit65","unstructured":"Iqbal AM Lopez RA Hai O Antiplatelet medications [updated 2020 Oct 23] www.ncbi.nlm.nih.gov\/books\/NBK537062\/"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart AssociationTask Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD013816.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0068|cit68","first-page":"e006273","article-title":"Frequency of cardiac rhythm abnormalities in a half million adults","volume":"11","author":"Khurshid","year":"2018","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"11","key":"10.1002\/14651858.CD013816.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00228-017-2296-1","article-title":"Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015","volume":"73","author":"Kjerpeseth","year":"2017","journal-title":"European Journal Of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0070|cit70","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"issue":"7","key":"10.1002\/14651858.CD013816.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1540-8159.2011.03150.x","article-title":"The 11th World Survey of Cardiac Pacing and Implantable Cardioverter-Defibrillators calendar year 2009 - a World Society of Arrhythmia's project","volume":"34","author":"Mond","year":"2011","journal-title":"Pace"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11239-015-1314-3","article-title":"Pharmacology of anticoagulants used in the treatment of venous thromboembolism","volume":"41","author":"Nutescu","year":"2016","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"24","key":"10.1002\/14651858.CD013816.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2012-05-423228","article-title":"Perioperative management of patients on chronic antithrombotic therapy","volume":"120","author":"Ortel","year":"2012","journal-title":"Blood"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/MDER.S15059","article-title":"Critical appraisal of cardiac implantable electronic devices: complications and management","volume":"4","author":"Padeletti","year":"2011","journal-title":"Medical Devices: Evidence and Research"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0076|cit76","unstructured":"Page M Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD013816.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2125.2006.02806.x","article-title":"Warfarin: almost 60 years old and still causing problems","volume":"62","author":"Pirmohamed","year":"2006","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD013816.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2307\/2532311","article-title":"A simple method for the analysis of clustered binary data","volume":"48","author":"Rao","year":"1992","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0079|cit79","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1540-8159.2008.02247.x","article-title":"Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators","volume":"32","author":"Robinson","year":"2009","journal-title":"Pace"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pace.12557","article-title":"Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study","volume":"38","author":"Sant' Anna","year":"2015","journal-title":"Pace"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0082|cit82","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0083|cit83","unstructured":"Shikdar S Bhattacharya PT International Normalized Ratio (INR) [updated 2020 Aug 22] www.ncbi.nlm.nih.gov\/books\/NBK507707\/"},{"issue":"3","key":"10.1002\/14651858.CD013816.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2009.03685.x","article-title":"Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?","volume":"8","author":"Steib","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis: JTH"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0085|cit85","first-page":"14898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/europace\/euv190","article-title":"Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)","volume":"17","author":"Sticherling","year":"2015","journal-title":"Europace"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0087|cit87","first-page":"476","article-title":"Warfarin: indications, risks, and drug interactions","volume":"39","author":"Tadros","year":"2010","journal-title":"Australian Family Physician"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0088|cit88","first-page":"1461","article-title":"Perioperative management of anticoagulant and antiplatelet therapy","volume":"104","author":"Tafur","year":"2018","journal-title":"Heart (British Cardiac Society)"},{"issue":"8","key":"10.1002\/14651858.CD013816.pub2-BIB0089|cit89","first-page":"1141","article-title":"Continuation versus interruption of direct oral anticoagulants for CIED procedures: new anticoagulants, old dilemma","volume":"3","author":"Tonko","year":"2021","journal-title":"Journal of the American College of Cardiology: Case Reports"},{"key":"10.1002\/14651858.CD013816.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joa.2015.11.003","article-title":"Mechanisms of cardiac arrhythmias","volume":"32","author":"Tse","year":"2016","journal-title":"Journal of Arrhythmia"},{"issue":"8","key":"10.1002\/14651858.CD013816.pub2-BIB0091|cit91","first-page":"556","article-title":"Updated guidelines on outpatient anticoagulation","volume":"87","author":"Wigle","year":"2013","journal-title":"American Family Physician"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013816.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-3016.2007.00908.x","article-title":"Exploring heterogeneity in meta-analyses: needs, resources and challenges","volume":"22","author":"Xu","year":"2008","journal-title":"Paediatric and Perinatal Epidemiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:36:18Z","timestamp":1775500578000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013816.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013816.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]}}}